Dashboard

View record

Title Therapeutic role of inhibitors of Hyaluronan in schwannoma associated with Neurofibromatosis type 2

File number 33/7/2019-TF/Rare/BMS

Funding agency ICMR

Start date Sept. 1, 2020

End Date Aug. 31, 2023

Duration Three Year

Disease category Neurofibromatosis type 2

Type of study None

Type of data None

Aims of objective To characterize and compare different molecular species of hyaluronan (HA) in the CSF of benign as well as malignant tumours of the CNS; To explore and compare the anti-proliferative role of HA inhibi

Keyword Neurofibromatosis Type 2, Schwannoma, Meningioma, Hyaluronic acid, CD44, Cerebrospinal fluid

Description None

Total Sanctioned budget 36,25,398/-

Principle Investigator Dr. Prasanth Ariyannur/None/Department of Molecular biology Amrita institute of medical sciences , Tamil Nadu

CoPrincipal Investigator Dr. Ashok Pillai/None/Amrita Institute of medical sciences , Kochi

CoPrincipal Investigator Sheela Nampoothiri/None/Dept. of Paediatric Genetics